Possibly, but I'm not ready to call that one :) Now that we know they're working on a manufacturing solution in the US, that could also mean they use the US as a template (FDA approval, manufacturing, and distribution models) to expand into other major markets, keeping Relief in tact. In that case, they would need a CEO and such. And/Or license out the rights to market the drug in each country to someone like Pfiser, J&J, or Eli (given their connections), which would also solve big pharma/political issues. We shall keep our ear to the ground.
(all speculation)
Market Data 
Markets 
AI
